Effectiveness of Mobile-health Self Management on Quality of Life of Patients Undergoing Chemotherapy

Not Applicable

Not yet recruiting

• Conditions: Quality of Life; Cancer; Chemotherapy Effect; Self Efficacy
• Interventions: Behavioral: Mobile-health self management

• Registration Number: NCT05881070
• Lead Sponsor: Universitas Muhammadiyah Yogyakarta

Brief Summary

The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.

Detailed Description

The study will design and evaluate the use of mobile-health based self-management on self-efficacy and quality of life of patients undergoing chemotherapy.

Study Timeline

• Status Verified: 2023-05
• Study First Submitted: 2023-05-08
• Study First Submitted QC: 2023-05-27
• Last Update Submitted: 2023-05-27
• Study First Posted: 2023-05-30
• Last Update Posted: 2023-05-30
• Study Start: 2023-06-15
• Primary Completion: 2023-08-31
• Study Completion: 2023-09-30

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• adult patients diagnosed with cancer
• patients who use smart phone

Exclusion Criteria

• patients with cancer with comorbidity

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Mobile health self-management	Mobile-health self management	-

Primary Outcome Measures

Name	Time	Method
Patient's Self-efficacy	four weeks	The patients self-efficacy will be measured pre and post intervention. The measurement will use the Self-Efficacy for Managing Chronic Disease Scale. The scale has been widely used in cancer setting. Respondents will rate their confidence to perform six self-management behaviours (1 = 'not at all confident' to 10 = 'totally confident'). A mean score is calculated (range 1 to 10). A high score indicates high self-efficacy.
Patient's Quality of life	Four weeks	The patient's quality of life will be assessed before (T0) and after intervention (T1). The measurement will use EORTC. The score will range from 0-100, where higher score reflects a better quality of life.